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The common bean (Phaseolus vulgaris L.) plays an important role in human nutrition, 
especially among low-income people in developing countries, primarily due to the high 
protein content of this legume, ranging from 19% to 27%. Previous studies have indicated 
that cooked bean bio-active peptides also exhibit anti-diabetic, antioxidant, and antimicrobial 
properties. It is hypothesized that small peptides (600-1000 Da) derived from different 
common bean strains are primarily responsible for eliciting bio-active effects. This project 
evaluated protein isolated extracts from 4 different strains of common bean for antioxidant 
capacity, anti-diabetic effects, and antimicrobial activity. Surprisingly, the bio-active 
compounds identified in this research revealed that the anti-diabetic effects of common bean 
extracts originate from lipids, not peptides. The findings that some bio-active properties of 
common bean extracts are of lipid origin are novel and previously unrecognized. Future in 
vitro and in vivo experiments are required to further identify and characterize the bio-active 
molecules from common bean strains that promote human health benefits. 







Summary for Lay Audience 
The common bean (Phaseolus vulgaris L.) plays an important role in human nutrition, 
especially among low-income people in developing countries, primarily due to the high 
protein content of this legume, ranging from 19% to 27%. Peptides are the intermediate 
products of protein digestion that occur in the human gastrointestinal system, and have 
unique physiological activities and beneficial properties to humans, which the original intact 
proteins do not have. This study focused on common bean small peptides, generated by a 
process that mimics cooking followed by digestion in the stomach. In particular, the 
antioxidant, anti-diabetic, and antimicrobial properties of extracts enriched with small bean 
peptides were assessed. We compared 4 different strains of common bean, which are 
genetically related but different in storage protein content, extracted proteins, and simulated 
the human gastrointestinal digestion process to generate small peptides. Peptides isolated 
from each bean strain were analyzed using multiple antioxidants, anti-diabetic, and 
antimicrobial tests. This study also looked further into specifically identifying the bio-active 
compounds in cooked common bean that exhibited anti-diabetic properties. 
Surprisingly, the bioactive compounds identified in this research revealed that the anti-
diabetic effects derived from common bean extracts appear to originate from lipids, not 
peptides. The findings that some bio-active properties of common bean extracts are of lipid 
origin are novel and previously unrecognized. Results of the study also showed that bioactive 
compounds exhibiting antimicrobial properties were probably also not peptides. These newly 
identified compounds may provide new antibacterial resources against bacterial drug 
resistance. However, more information is required to identify the nature of the bioactive 
molecules precisely. Studies of antioxidant capacity suggest that the bioactive molecules 
were probably a mixture of small peptides. Future in vitro and in vivo experiments are 
required to further identify and characterize the bio-active molecules from common bean 
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Chapter 1: Introduction 
1.1 Common bean 
As one of the most favoured food worldwide, the common bean (Phaseolus vulgaris L.) 
accounts for 50% of the grain legume consumption for humans (McClean et al., 2004). 
Botanically, P. vulgaris is a dicotyledonous annual plant, and it is a true diploid with 11 
chromosomes (2n = 2x = 22, n=11) belonging to the Family Fabaceae, and  domesticated and 
dispersed from their wild-type ancestor originating in Mesoamerica and the Andes (Koenig 
and Gepts, 1989). The genome size of P. vulgaris is small [580 million base pair 
(MBp)/haploid genome] and is comparable to that of rice (340 560 MBp/haploid genome), 
which is the smallest genome among economically important plants recognized by the United 
State Department of Agriculture (USDA) (Broughton et al., 2003; Gepts et al., 2008). Most 
common beans are self-pollinating plants; however, cross-pollination may occur in some real-
world situations; for example, when the stigma grows overlength and is touched by 
pollinating insects (Ibarra-Perez et al., 1997). Although common beans are similar 
botanically, the seed size (about 7-16 mm long and without endosperm), colour (white, red, 
black, brown, or mottled), and shape (oval, oblong or kidney shape) vary greatly (Katungi et 
al., 2009). With a long cultivation history, over 600 known varieties of common beans are 
grown globally, 62 of them being recognized as commercial market classes, including Pinto, 
Navy, Small White, Cranberry, and Kidney (Azarpazhooh and Boye, 2012).  The current 
distribution of the wild common bean is from northern Mexico to Northwestern Argentina, 
and there are two major eco-geographical gene pools: Mesoamerica and the Andes (Bitocchi 
et al., 2012).  
As traditional plants that have existed for over 7000 years globally (Câmara et al., 2013), the 
common beans always have a worthy place in human diets. Based on the Food and 
Agriculture Organization in 2018 (http://www.fao.org/faostat/en/#data/QC, accessed 18 April, 
2020), world production of the dry bean was 30,434,280 tonnes, which has increased by 
almost 120% since 1980. India is the largest producer, estimated at approximately 6.22 
million tonnes, followed by Myanmar, Brazil, the USA, and China. Canada was ranked 16th 
in 2018, with a common bean production of 341,110 harvested tonnes. By contrast, according 
to international trade data from the Canada was 
the 3rd largest exporter in the world of kidney beans and white pea beans dried shelled in 




(15.9%, $258 million) and China (14.5%, 235 million), with 44.2% of exported beans going 
to the United Kingdom ($64.8 million) (https://oec.world/en/visualize/tree-
map/hs92/export/can/all/2071333/2018/, accessed 7 June, 2020) 
 
1.2 Nutrients of common bean 
1.2.1 The nutrient value of the common bean 
According to epidemiological studies, diets rich in legumes are positively linked to longevity, 
improved heart health, and reduced risk for many types of cancers (Câmara et al., 2013). The 
common bean is rich in carbohydrates (60%), proteins (19%-27%), fibre, and it is a good 
source of unsaturated fatty acids, vitamin B complex, and a variety of chemical trace 
elements (Montoya et al., 2010). Because of the high amount of protein and dietary fibre but 
the very low-fat content in common beans (approximately two times higher protein than 
major cereals, Table 1 - 1), they became a staple food for low-income people in rural and 
urban areas in many developing countries where animal proteins are expensive and protein-
energy malnutrition is prevalent (Lima et al., 2005). Because of the high content of proteins 
in common beans, this project was focused on how these proteins benefit the human body 
after cooking processes.  
 
Table 1 - 1: Comparison of nutritional profiles of dry beans with major grains (per 
100g). Adapted from the USDA (https://fdc.nal.usda.gov/, accessed 19 April, 2020) 
 Dry Beans Wheat Oat Corn Sorghum 
Energy (Kcal) 337 342 379 365 329 
Protein (g) 22.33 11.31 13.15 9.42 10.62 
Total lipid (fat) (g) 1.5 1.71 6.52 4.74 3.46 
Carbohydrates (g) 60.75 75.9 67.7 74.26 72.09 
Fiber, total dietary(g) 15.3 12.2 10.1 7.3 6.7 
Sugars 3.88 0.41 0.99 0.64 2.53 
Calcium (mg) 147 32 52 7 13 
Iron (mg) 5.49 4.56 4.25 2.71 3.36 
Potassium (mg) 1185 355 362 287 363 





1.2.2 Seed storage proteins of common bean 
1.2.2.1 Seed storage proteins of common bean 
Despite the high protein content of the common bean, its protein quality is sub-optimal due to 
the low amount of two nutritionally sulfur amino acids: cysteine (Cys) and methionine (Met, 
essential amino acid) (Pandurangan et al., 2015). The low sulfur amino acid content in the 
common bean is primarily attributed to high globulin levels, which acts as storage proteins 
for subsequent seed germination. As a sink for nitrogen, globulins are rich in nitrogen-rich 
amino acids, which are degraded after germination to provide nitrogen for the construction of 
new proteins (Shewry et al., 1995). However, globulin proteins lack the two sulfur-containing 
amino acids (Cys and Met) (Boulter and Croy, 1997). Globulins can be further divided into 
11S globulin (legumin) and 7S globulin (phaseolin) fractions by their sedimentation 
coefficients (Marsolais et al., 2010; Shewry et al., 1995; Taylor et al., 2008).  
Phaseolin, composed of 2 to 6 polypeptides, is the major globulin in common beans with 
molecular weights ranging from 43 to 54 kDa (Osborn and Brown, 1988). There are three 
major types of phaseolin in different common bean varieties, which first identified by Brown 
et al. (1981) using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), 
and named after their cultivars of origin . 
According to Acquaah et al. (1994), 49.2% of common bean accessions from Malawi in 
Africa had the Tendergreen  type phaseolin, 24.8% had the Contender  type, and 23.5% 
had the Sanilac  type. Lectins are seed storage proteins found in common bean, with 
molecular weights between 27 and 37 kDa (Sathe, 2002). P -amylase 
inhibitors belong to lectins, and each contributes about 10% of seed protein, respectively 
(Marsolais et al., 2010). Lectins are anti-nutritional factors, which means they can block the 
absorption of nutrients by inhibiting gastrointestinal digestive enzymes or cell agglutinating 
activities (Vasconcelos and Oliveira, 2004). Lectins are compounds designed to prevent 
bacterial infections and insect consumption (Peumans and Van Damme, 1995), which is why 
they are hard to be absorbed in the raw state. However, they are thermolabile after proper 
cooking processes (Vasconcelos and Oliveira, 2004). Arcelin is another seed storage protein 
found in wild bean varieties (Osborn et al., 1986) and acts as a growth inhibitor on bruchid 




1.2.2.2 Improvement of protein quality in grain legumes 
During the past decades, attempts have been made through breeding programs or transgenic 
approaches to improve the protein quality of the grain legumes due to the low amount of two 
nutritionally sulfur amino acids Cys and Met (Aragão et al., 1999; Bliss and Brown, 1983; 
Gepts and Bliss, 1984; Taylor et al., 2008). The principal target has usually been phaseolin 
since it is the major seed storage protein that constitutes up to 50% of the total seed protein in 
commercial cultivars while deficient in Met and Cys (Marsolais et al., 2010). Taylor et al. 
(2008) found that the reduction of the non-protein amino acid S-methylcysteine in 
commercial common bean cultivars, resulted in the preferential increase in the concentration 
of Met and Cys in seed storage protein-deficient lines. This discovery gave a new way to 
improve the protein quality of commercial common bean cultivars. 
 
1.2.2.3 Peptides 
Peptides are an intermediate product of protein degradation and have unique physiological 
activities and beneficial properties to humans, which the original protein and individual 
amino acids do not have. In common bean peptides, these benefits include anti-inflammatory 
(García-Lafuente et al., 2014), anti-diabetic (González-Montoya et al., 2018), antioxidant 
(Carrasco-Castilla et al., 2012), anti-hypertensive (Garcia-Mora et al., 2016) and anti-
carcinogenic effects (Câmara et al., 2013). In this project, we primarily focused on 
antioxidant, anti-diabetic, antimicrobial, and anti-lipogenic properties of common bean 
peptides. 
 
1.3 The non-nutritional value of common bean peptides 
1.3.1 The importance of antioxidants in the human body 
The antioxidant capacity of natural foods to counter the harmful effects of free radicals has 
attracted increased attention (Lobo et al., 2010). Reactive oxygen species (ROS) are unstable 
molecules containing oxygen that can promote the oxidation of various biological 
macromolecules. Cellular oxidative stress occurs when there is either an increased production 




damage DNA, RNA, lipids and proteins, potentially leading to the death of cells, tissues, and 
organs, and is believed to be a contributing factor to multiple diseases such as cardiovascular 
diseases, chronic kidney diseases, and cancer (Liguori et al., 2018). Antioxidants can capture 
and neutralize free radicals, thereby preventing cellular oxidative damage (Oseguera-Toledo 
et al., 2011). Glutathione, an abundant thiol-containing tripeptide produced in most 
organisms, can undergo oxidation and reduction cycles to detoxify ROS (Pompella et al., 
2003). According to Zou et al. (2016), antioxidant capacity in the Pinto bean derived peptide 
was mainly found in molecular weight fractions < 3 kDa.  
 
1.3.2 Diabetes and bean peptides 
Diabetes mellitus is a severe chronic disease worldwide that occurs when the human body 
cannot lower the blood sugar levels either because pancreatic -cells do not produce enough 
insulin or the body does not respond to the produced insulin (Nair et al., 2013). In 2014, over 
422 million adults were diagnosed as diabetic (Zhou et al., 2017). Moreover, in 2016, 
diabetes was identified as the 7th leading cause of death globally. Diabetes is broadly 
classified under three categories of hyperglycemia, including type 1 diabetes, type 2 diabetes, 
and gestational diabetes (https://www.who.int/news-room/fact-sheets/detail/diabetes, 
accessed on April 3, 2019). Type 1 diabetes, formerly known as insulin-dependent diabetes, 
occurs mainly in children or adolescents. It is characterized by a severe lack of insulin 
secretion in pancreatic cells, which means insulin must be injected daily; otherwise, it is life-
threatening (Al-Goblan et al., 2014). Type 2 diabetes, initially called non-insulin-dependent 
or adult-onset diabetes, use insulin effectively, and 
usually occurs after 35 to 40 years of age, accounting for more than 90% of the diabetic 
patients (Ginter and Simko, 2013). The difference between type 2 diabetes and type 1 
diabetes is that the ability to produce insulin in patients with type 2 diabetes is not entirely 
lost; some patients even produce too much insulin from pancreatic -cells. However, the 
cellular insulin response is weak, resulting in insulin resistance (Kahn et al., 2006). 
Gestational diabetes mellitus (GDM) is a particular case of type 2 diabetes that can occur 
during pregnancy, with elevated blood glucose levels that are higher than usual but do not 
reach the diagnostic value of diabetes. There are more than 200,000 cases of GDM annually, 
representing approximately 7% of the total pregnancies (American Diabetes Association, 




inhibit dipeptidyl peptidase-4 (DPP-IV) activity, a target of several anti-diabetic medications 
to lower the blood sugar level (Matteucci and Giampietro, 2009), as a treatment for type 2 
diabetes. 
DPP-IV is a serine exopeptidase located at the cell surface, with a primary function to affect 
extracellular proteins by cleaving target polypeptides that have alanine or proline at the 
penultimate end of the N-terminus, and most cleaved substrates will lose their biological 
activity (Matteucci and Giampietro, 2009). DPP-IV can cleave a broad range of substrates, 
including incretins, Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic 
polypeptide (GIP). Incretins promote the release of insulin and inhibit glucagon (a hormone 
with a promotion of glycogenolysis and gluconeogenesis, resulting in the increase of glucose 
in the blood) release when blood sugar levels are elevated, thereby lowering blood glucose 
levels. Inhibitors that block the DPP-IV enzyme and prevent the inactivation of incretins have 
been evaluated for their use in treating type 2 diabetes mellitus (Röhrborn et al., 2015). 
According to Oseguera-Toledo et al. (2015), common bean derived peptides with molecular 
weight <1 kDa have a strong ability to promote DPP-IV inhibition and enhanced glucose-
stimulated insulin secretion. The -amylase and -glucosidase enzymes are also key enzymes 
associated with type 2 diabetes since they catalyze the starch hydrolysis into glucose (Nair et 
al., 2013). The -amylase is predominately found within the human body in saliva and 
pancreatic juice -glucosidase is located in the brush border of the small intestine; these 
enzymes work together to break down starch and disaccharides into glucose (Bonnefond et 
al., 2017; Ramkumar et al., 2010). The inhibitors for these two enzymes are also called 
are now used as anti-diabetic medicines that help to lower post-meal 
blood glucose levels (Zhang et al., 2020). Research has also shown that common bean 
derived peptides can significantly reduce the digestion of starchy food (69.2% - 93.3%) by 
inhibiting the activity of -amylase and -glucosidase enzymes, further highlighting their 
potential use as a functional or medicinal food for type 2 diabetes  (Mojica et al., 2015; Obiro 
et al., 2008; Zhang et al., 2020). 
 
1.3.3 Obesity and bean peptides 
Obesity is also a global public health problem, and has a strong relationship with insulin 




overweight, in general, is the energy imbalance between calorie intake and expenditure, and it 
is recognized as an independent predictor of non-communicable diseases such as 
cardiovascular disease and diabetes (Flegal et al., 2005). The World Health Organization 
reported that in 2016, over 1.97 billion and 650 million adults worldwide were expected to be 
overweight and obese, respectively (https://www.who.int/news-room/fact-
sheets/detail/obesity-and-overweight, accessed on Feb 25, 2019). Martinez-Villaluenga et al. 
(2008) showed -conglycinin, a major seed storage 
protein in soybean, can effectively inhibit lipid accumulation in 3T3-L1 adipocytes in vitro, 
thus suggesting that the epidemic of obesity/overweight may be mitigated by consumption of 
bean derived proteins. 
 
1.3.4 Antimicrobial 
The first antibiotic, penicillin, was accidentally discovered by Alexander Fleming on 
September 3, 1928 (Aminov, 2010). Since then, various antibiotics have been widely used to 
treat human infectious diseases. Antibiotics are known to have the initial strength of being 
effective in treating pathogenic bacteria, but they lose their antimicrobial ability over time 
due to the abuse of various antibiotics (Lei et al., 2019). The abuse of antibiotics can promote 
drug-resistant bacteria, which leads to severe health problems worldwide and causes over 
700,000 deaths annually (Pokharel et al., 2020). Drug resistance in bacteria has now become 
an urgent problem, and it was the theme of the World Health Day 2011 
. Thus, the development of new antibiotics or other new 
antibacterial resources has become an urgent need and is catching more attention from 
scientists worldwide.  
Antimicrobial peptides (AMPs) are part of the innate immune system and can be found 
among almost all kinds of organisms. AMPs are a class of small peptides that are 10 to 60 
amino acids in length, and most of them are positively charged (average net charge: 3.32) 
(Huan et al., 2020; Jenssen et al., 2006). AMPs can work efficiently against bacteria, fungi, 
parasites, and viruses by binding to and disrupting the outer membrane. Because they are not 
easily affected by the evolution of bacterial resistance, AMPs are considered a promising 
class of new antibiotics (El Shazely et al., 2020). Plant AMPs can be isolated from roots, 




multiple disulfides bridges to enhance structural stability and can be classified into thionins, 
defensins, hevein- and knottin-type peptides, and lipid transfer proteins (Meneguetti et al., 
2017; Nawrot et al., 2014). During the past decades, plant AMPs have attracted the attention 
of the pharmaceutical industry and the scientific community, and their biotechnological 
potential for the treatment of human diseases has been demonstrated (de Souza Cândido et al., 
2014; Meneguetti et al., 2017). For example, Franco et al. (2006) found that AMPs derived 
from the cowpea (Vigna unguiculate) defensin II (CP-thionin II) protein can be effective 
against Staphylococcus aureus, which is a gram-positive bacterium that causes major 
infections in the human body, including abscesses of the skin and sinusitis of the respiratory 
system (Lowy, 1998). Thus, it can be envisaged that plant AMPs will become valuable 
therapeutic tools against pathogens to protect human health in the next few years. 
 
1.4 Agronomic characteristics of the bean germplasm used in 
this project 
In this study, the common bean strains Sanilac, SARC1, SMARC1-PN1, and SMARC1N-
PN1, were used to characterize and identify the bioactive peptides that exhibit antioxidant 
capacity, anti-diabetic effects, antimicrobial and anti-lipogenic ability. Sanilac is a 
commercial cultivar containing two major seed storage proteins: phaseolin and lectins. 
SARC1 is a hybridized variety between Sanilac and a wild accession G12282  containing 
arcelin-1 protein, so it has all three major seed storage proteins: arcelin-1, phaseolin, and 
lectins. In addition, the introduction of arcelin-1 is associated with an approximately 3-fold 
decrease of phaseolin levels in SARC1, thus arcelin-1 functions as the main storage protein 
rather than phaseolin (Marsolais et al., 2010). The SARC1 line was further introgressed with 
recessive mutation varieties Phaseolus coccineus  and Great Northern 1140 , which 
conferred a deficiency in phaseolin and lectins, respectively. SMARC1-PN1 contains arcelin 
and lectins but lacks phaseolin, while SMARC1N-PN1 lacks all three major seed storage 
proteins (Figure 1 - 1). The genomes of all three hybridized lines share 85% identity with 
their parental cultivar Sanilac (Taylor et al., 2008). The total seed protein content for all four 
varieties is not significantly different. Deficiencies in major seed storage proteins are 







Figure 1 - 1: Protein extracts from Sanilac, SARC1, SMARC1-PN1 and 
SMARC1N-PN1. Cultivars were resolved by SDS-PAGE, followed by Commassie 
Blue staining to reveal the prominent seed storage proteins as indicated by arrows: 
Phaseolin (47.5 kDa), arcelin-1 (35 kDa), and Phytohemagglutinin (32 kDa) [Adapted 






I hypothesize that small bio-peptides (600-1000 Da) derived from common bean proteins 
during cooking/digestion conditions will exhibit antioxidative, anti-lipogenic, and 
antimicrobial properties, in addition to inhibitory effects on DPP-IV, -amylase, -
glucosidase enzymatic activity. 
 
1.6 Research objectives  
1. Extract and purify protein isolates from common beans and mimic the cooking process 
and human digestion to generate small bio-peptides. 
2. Characterize the antioxidant properties of common bean derived small bio-peptides using 
in vitro assays. 
3. Determine if common bean small bio-peptide isolates can inhibit DPP-IV in vitro. 
4. Assess the capacity of common bean small bio-peptides to inhibit starch digestion. 
5. Evaluate the potential of common bean small bio-peptides to inhibit fat accumulation in 
cultured 3T3-L1 adipocytes. 
6. Test antimicrobial ability of common bean small-bio-peptide by bacterial culture. 





Chapter 2: Materials and Methods 
2.1 Plant material 
The Common bean (Phaseolus vulgaris L.) genotype Sanilac, SARC1, SMARC1-PN1 and 
SMARC1N-PN1 seeds were sown and germinated in vermiculite, and 12-day old seedlings 
were transplanted into 17 × 20 cm plastic pots containing Promix BX potting medium 
(Premier Tech Horticulture, Québec, Canada). Plants were grown in growth cabinets 
(Environmental Growth Chambers, Chagrin Falls, OH, USA) and regularly fertilized with a 
nitrogen, phosphorous, and potassium (20-20-20) mixture. The temperature in the growth 
cabinets was set at 24 ºC under 16 h light (300- -2 s-1) and 18 ºC under 8 h 
dark (Pandurangan et al., 2012).  
 
2.2 Determination of peptide concentration of the cooked beans  
2.2.1 Protein isolates extraction  
Four common bean samples (20 g of each variety) were cooked in 350 mL boiling water for 1 
h and 15 min, strained, and beans were cooled down to room temperature. The pH of a 1:5 
(w/v) bean paste/water ratio solution was adjusted to 8.0 with 0.1M NaOH, and then the 
solution was  at 
15,000 × The remaining pellet was extracted twice under the same conditions to 
maximize the protein extraction yield, and all extracts were mixed. The supernatants were pH 
adjusted to 4.3 with 0.1 M HCl, then centrifuged for 30 min at 20,000 × 
protein isolates (BPI) pellet were lyophilized in a LABCONCO FreeZone Freeze Dry System 
(Kansas, MO, USA). Dried BPI was stored at -20  until further analysis (Mojica and de 
Mejía, 2016).  
 
2.2.2 Simulation of gastrointestinal digestion 
To mimic gastrointestinal digestion of the common bean proteins, the BPI was resuspended 
in water (1:50 w/v), and digested using pepsin (EC 3.4.23.1; > 2,500 units/mg; purchased 
from Sigma-Aldrich, St. Louis, Mo., U.S.A.) for 2 h at  in a 1: 75.6 (w/w) enzyme: BPI 




from Sigma-Aldrich, St. Louis, Mo., U.S.A.) for another 2 h at  in a 1: 20 (w/w) 
enzyme: BPI ratio (pH 7.5). The protein hydrolysis was stopped by heating at 75  for 20 
min, then the sample was cooled down to room temperature and centrifuged for 30 min at 
35,000 × g at 4  to collect the supernatant, known as the BPI hydrolysate (BPIH). The 
BPIH was filtered through a 0.8 m filter, then dialyzed using 500 Da molecular weight cut-
off dialysis membrane (VWR, Mississauga, ON) to eliminate salts, and lyophilized in a 
LABCONCO freeze dry system. Dried BPIH was stored at -20  until further analysis 
(Mojica et al., 2015).  
 
2.2.3 Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) analysis of the digested peptides profile 
The BPI and BPIH were analyzed by SDS-PAGE to separate proteins (Oseguera-Toledo et 
al., 2011). Six microliters of 5 × SDS protein sample buffer was added to 10  of the BPI or 
BPIH extract with 14  of Milli Q water in a 1.5 mL tube. Samples were vortexed and 
heated at 95  for 5 min and centrifuged for 1 min at 25,000 × g at room temperature 
(24 ). Thirty microliters of these samples were loaded on a 10% acrylamide SDS-PAGE 
gel, and then the Coomassie Blue R250 was used for staining the SDS-PAGE gel to visualize 
proteins and peptides (Mojica et al., 2015). 
 
2.2.4 Determination of the quantity of digested peptides  
Peptides were quantified using the PierceTM Quantitative Colorimetric Peptide Assay (#23275, 
Rockford, IL. USA). This assay was modified using bicinchoninic acid (BCA) reagents with 
a chelator to quantify the concentration of the peptides. The principle of this assay is the 
biuret reaction or copper-based reaction, in which the amide backbone of peptides can reduce 
Cu2+ to Cu+ under alkaline condition, the chelator, then, binds with Cu+ to form an orange 
complex with an absorbance of 480 nm. Twenty microliters of 1000 g/mL BPIH sample 
extract or peptide digest assay standards (0-1000 g/mL) were added into a 96-well plate 
with 180  colorimetric peptide assay working reagent. The mixture was pre-incubated 
for 30 min at 22 , then the absorbance was read with a Synergy 2 multiwell plate reader 





2.2.5 Matrix Assisted Laser Desorption / Ionization-Time of 
Flight/Time of Flight system (MALDI-TOF/TOF) analysis of 
the digested peptides molecular mass profile 
MALDI TOF/TOF was used for analyzing the molecular mass profile of common bean 
BPIH at Western University MALDI Mass Spectrometry Facility, Department of 
Biochemistry, to assess the molecular mass range of peptides from 600-3000 Da. Dried BPIH 
samples were re-dissolved in water (0.5 g/L) and mixed with MALDI matrix (5.5 g/L 
cyano 4 hydroxycinnamic acid in 6 mM ammonium phosphate monobasic, 50% acetonitrile, 
0.1 % trifluoroacetic acid) at 1:1 ratio (v/v), and 0.75  of this mixture was spotted on the 
MALDI plate. Mass Spectrometry data were obtained using an AB Sciex 5800 TOF/TOF 
System, MALDI-TOF/TOF (Framingham, MA, USA). Data acquisition and data processing 
were done using a TOF/TOF Series Explorer and Data Explorer (both from AB Sciex), 
respectively. The instrument was equipped with a 349 nm Nd: YLF OptiBeam On-Axis laser. 
The laser pulse rate was 400 Hz. Reflection positive mode was used and externally calibrated 
at 50 ppm mass tolerance. Each mass spectrum was collected as a sum of 775 shots in the 
mass to charge range from 600 to 3000 m/z. The range below 600 m/z was eliminated due to 
matrix adduct peaks contamination. 
 
2.3 Characterization of common bean bio-peptides 
2.3.1 Antioxidant capacity of common bean peptides 
2.3.1.1 Oxygen radical absorbance capacity (fluorescein-
ORAC) assay 
The ORAC assay employs fluorescein (FL, EC 219-031-8, purchased from Sigma-Aldrich, St. 
Louis, Mo., U.S.A.) as the fluorescent probe -azobis (2-methylpropionamidine) 
dihydrochloride (AAPH, EC 221-070-0, purchased from Cayman, Michigan, U.S.A.) as the 
source of peroxyl radical, and using the difference between the area under the fluorescence 
decay curve (AUC) and the natural decay curve of fluorescence as an indicator of the 
antioxidant capacity of the sample. Results were expressed in units of 6-hydroxy-2, 5, 7, 8-




Aldrich, St. Louis, Mo., U.S.A.), a calibration standard used to quantify the antioxidant 
capacity of a sample (Ou et al., 2001). Based on Dávalos et al. (2004) and Prior et al. (2003), 
the ORAC assay was performed in 75 mM phosphate buffer (pH 7.4). Twenty microliters of 
0.1 g/L BPIH, Trolox standards (0- or buffer were added into a black 96-well plate 
 was pre-
microliters of 40 mM AAPH was added rapidly to all wells using multichannel pipettes 
except the assay control (which received ), and absorbance was read 
immediately with a Synergy 2 multiwell plate reader. The relative fluorescence units were 
read at 485 +/- 20 nm (excitation) and 516 +/- 20 nm (emission) every minute for 90 min at 
37 The ORAC-FL assay is based on the principle that the fluorescent probe is quenched 
by peroxyl radicals over time by the hydrogen atom transfer process, while the oxidation of 
peroxyl radicals for the fluorescent probe is blocked by antioxidants until the antioxidant 
capacity in the sample is exhausted. The difference between the area under the fluorescence 
decay curve of the sample and the natural decay curve of fluorescence is used as an indicator 
of the antioxidant capacity of BPIH samples (Figure 2 - 1). Results were expressed as 







Figure 2 - 1: Illustration of the antioxidant capacity of the sample expressed as the net 
area under the curve (Net AUC). The difference between the area under the fluorescence 
decay curve of sample and the natural decay curve of fluorescence was used as an indicator 







2.3.1.2 Ferric reducing/antioxidant power (FRAP) assay 
The FRAP assay is used for determining the total antioxidant capacity of a sample. The 
principle for this experiment is based on single electron transfer that the antioxidant can 
reduce the yellow-colored ferric-tripyridyl-triazine (Fe3+-TPTZ) complex under acidic 
conditions to produce a blue-colored ferric form (Fe2+-TPTZ), and then the absorbance can be 
measured at 593 nm (Guo et al., 2003). The FRAP assay was done according to Khanizadeh 
et al. (2008) with some modifications. Briefly, 10  of BPIH sample extract (1-10 g/L), 
Milli Q water, or standards (ascorbic acid, 62.5-1000 ,) were added into a 96-well plate 
with 300 working FRAP reagent [prepared by mixing 300 mM acetate buffer, pH 3.6, 
10 mM TPTZ (EC 222-965-9, purchased from Sigma-Aldrich, St. Louis, Mo., U.S.A.), and 
20 mM FeCl3·6H2O in the ratio of 10:1:1]. The plate was incubated at room temperature for 2 
h in the dark, then the absorbance read at 593 nm with a Synergy 2 multiwell plate reader. 
Like the ORAC assay above, results were compared with the standard and expressed as 
micromoles ascorbic acid equivalents per gram of dry BPIH extracts ( mol AAE/g). 
 
2.3.2 DPP-IV inhibition experiment 
DPP-IV inhibition was measured following the DPPIV-GloTM Protease Assay (G8351, 
Promega) (Figure 2 - 2: The principle of DPP-IV inhibition experiment. The Gly-Pro 
sequence in the luminogenic substrate is recognized and cleaved by the DPP-IV enzyme. 
Aminoluciferin, the resulting product, is further recognized by luciferase to generate 
luminescence that can be detected by a plate reader. 
). This experiment was carried out in DPP-IV assay buffer (100 mM Tris-HCl, pH 8.0, 1 mM 
EDTA and 200 mM NaCl) (Mojica et al., 2015). Sitagliptin (CAS 654671-78-0, purchased 
from Toronto Research Chemicals, North York, ON, Canada) was used as positive control in 
this experiment since it is a medication used to treat type 2 diabetes by inhibiting the DPP-IV 
enzyme (Herman et al., 2005; Parmar et al., 2012). the 
buffer, BPIH (0.1-3.2 g/L) or positive control (4nM Sitagliptin) 
DPP-IV human enzyme (ProSpec, East Brunswick, NJ, U.S.A.)  were added into a white 96-
-GloTM reagent. After mixing and pre-incubation for 30 min 




were expressed as the concentration of the sample that reaches half-maximal inhibition (IC50) 
of the DPP-IV enzyme as calculated using Graph Pad Prism 6.0. 
 
  
Figure 2 - 2: The principle of DPP-IV inhibition experiment. The Gly-Pro sequence 
in the luminogenic substrate is recognized and cleaved by the DPP-IV enzyme. 
Aminoluciferin, the resulting product, is further recognized by luciferase to generate 





2.3.3 -amylase inhibition assay 
For the -amylase assay, 250  of BPIH sample extracts (0.1-1 g/L), positive control (1 mM 
acarbose, EC 260-030-7; purchased from Sigma-Aldrich, St. Louis, Mo., U.S.A.), or negative 
control (Milli Q water) were added into a 1.5 mL tube with 250  of 13 U/mL -amylase 
[(EC 232-565-6; purchased from Sigma-Aldrich, St. Louis, Mo., U.S.A) carried out in 0.02 
M sodium phosphate buffer, pH 6.9], while the blank tube was mixed with 250 02 M 
sodium phosphate buffer (pH 6.9) and 2 . After mixing and incubating 
for 10 min at 25  250  of 1% starch (previously dissolved in 0.02 M sodium phosphate 
buffer, pH 6.9, and boiled for 15 min) was added into each tube, and tubes were incubated 
again under identical conditions. Then, 500  dinitrosalicylic acid color reagent [prepared 
by dissolving 1.0 g of 3,5-dinitrosalicylic acid (EC 210-204-3; purchased from Sigma-
Aldrich, St. Louis, Mo., U.S.A.) in 50 mL of Milli Q water, then adding 30.0 g sodium 
potassium tartrate tetrahydrate (EC 206-156-8; purchased from Sigma-Aldrich, St. Louis, 
Mo., U.S.A.), 20 mL of 2N NaOH, and finally diluted to 100mL with Milli Q water] was 
added into each tube and incubated at 100  activity. The 
mixture was diluted by adding 5 mL of Milli Q water then 1.5 mL of solution was transferred 
into a cuvette and the absorbance at 540 nm was determined using a BioPhotometer 
(Eppendorf, Mississauga, ON). Results were expressed as percent inhibition relative to the 
positive and negative control (Mojica and de Mejía, 2016). 
 
 
2.3.4 -glucosidase inhibition assay 
For the -glucosidase assay, 50  of BPIH sample extracts (0.1-1 g/L), positive control (1 
mM acarbose), or negative control (Milli Q water) were added into a 96-well plate with 100 
1 U/mL -glucosidase [(EC 3.2.1.20; purchased from Sigma-Aldrich, St. Louis, Mo., 
U.S.A.) carried out in 0.1 M sodium phosphate buffer, pH 6.9]. In contrast, the blank well 
was mixed with 100  of 0.1 M sodium phosphate buffer (pH 6.9) and 50  of Milli Q 
water. After mixing and incubating for 10 min at 25  50  of 5 mM p-nitrophenyl- -D-
glucopyranoside (EC 223-189-3; purchased from Millipore Sigma, St. Louis, Mo., U.S.A.) 




incubated for another 5 min at 25 . The absorbance of the mixture was then read at 405 nm 
with the Synergy 2 multiwell plate reader. Results were expressed as percent inhibition 
relative to the positive and negative control (Mojica et al., 2015). 
 
 
2.3.5 Lipid accumulation inhibition assay 
2.3.5.1 Tissue culture and treatments 
For cell culture, different quality of common bean bio-peptides were tested. BPI was pre-
before pepsin/pancreatin digestion following the procedure described by Martinez-
Villaluenga et al. (2009). 3T3-L1 fibroblasts (ATCC® CCL-92.1TM, Manassas, VA, USA) 
were seeded in a 6-well plate (6 103 cells/cm2) with Dulbecco's Modified Eagle's Medium 
(DMEM) containing 10% Fetal Bovine Serum (FBS), 10 mM sodium pyruvate, 100 U/mL 
streptomycin and 100 U/mL penicillin (also called FBS/DMEM medium) and grown until 
reaching 100% confluence. Two days after reaching 100% confluence, fibroblast cells were 
induced to differentiate to adipocytes by culturing in FBS/DMEM containing 167 nM insulin, 
-isobutyl-1 methylxanthine for two days, followed by 
two additional days in FBS/DMEM with 167 nM insulin. After four days of FBS/DMEM 
culturing, 90% of preadipocytes were differentiated into adipocytes (as evidenced by 
accumulation of fat droplets). Mature adipocytes were cultured separately with 100  BPIH 
for 72 hours. All cells were cultured in VWR water-jacketed, CO2 incubator (VWR, 
Mississauga, ON) at 5% CO2 and 37 conditions (Martinez-Villaluenga et al., 2009). 
 
2.3.5.2 Lipid quantification in 3T3-L1 adipocytes by Oil Red 
O assay 
An Oil Red O assay was used to measure the ability of the BPIH sample to inhibit lipid 
-buffered saline 




with 60% isopropanol and dried completely. Fat droplets were stained with Oil Red O 
solution (6:4 v/v with water) for 10 min, then cells were washed four times with water to 
remove staining solution, followed by air-drying. Oil Red O was destained with 100% 
isopropanol for 10 min, then the absorbance of the isopropanol wash was read at 510 nm 
using the BioPhotometer (Martinez-Villaluenga et al., 2009). 
 
2.3.6 Antimicrobial susceptibility test 
Antimicrobial susceptibility test was performed to measure the ability of all 4 common bean 
BPIH to inhibit the bacteria growth with 7 bacterial cultures: Bacillus subtilis, Erwinia 
carotovora, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, 
Staphylococcus aureus, and Salmonella Heidelberg. Mueller Hinton agar was used in this 
experiment for both bacteria growth and antimicrobial susceptibility test. Several bacteria 
colonies were picked from an agar plate using a loop and transferred to 0.9% NaCl solution. 
Following an adjustment of turbidity to match a 0.5 McFarland standard (1 × 108 cells/mL), 
bacteria were incubated for 15 min. After that, a swab was dipped into the inoculum and 
rotated against the wall of the tube above liquid to remove excess inoculum. This inoculated 
swab that contained bacteria was then dispersed across the entire surface of a new sterile agar 
plate three times to complete the inoculation. For the experiment, 50 mg of each dry BPIH 
samples was re-suspended in 1 mL of 0.01% acetic acid and 0.2% BSA (50 mg/mL), and 
spotted 5 L onto each bacteria agar plate. After allowing the BPIH samples to dry, all plates 
were cultured in an ambient-air incubator (Thermo Fisher, Burlington, ON) overnight at 
37 , and the condition of bacterium growth were observed and recorded. All experiment 
were carried out under sterile conditions (Lalitha, 2004). 
 
2.4 Sequence identification of the bio-active compounds 
2.4.1 Pre-separation of bio-active compounds 
To identify the bioactive compounds in BPIH samples that work for each experiment we 
talked above, the BPIH was preliminarily separated by solid-phase extraction (SPE), which is 
a convenient method for sample preparation, separation, and purification based on the 




dialysis, the BPIH were directly loaded on to a Bond Elut Plexa SPE column (Agilent 
Technologies, California, U.S.A.) without freeze drying to maximize the retention of active 
compounds, then eluted with 0 to 100 % gradient of MeOH in water as a mobile phase to 
separate bio-compounds which have DPP-IV inhibition and antimicrobial property. For 
antioxidant capacity, an additional SPE column, C18 Cartridges (Waters, Milford, U.S.A.), 
with acetonitrile (ACN) + 0.1% trifluoroacetic acid (TFA) were used as a mobile phase for 
eluting. The whole process was carried out in a vacuum extraction manifold (Waters, Milford, 
U.S.A.). Each time the assay was performed, a negative control (Milli Q water with pepsin 
and pancreatin) was run along with the samples to ensure all active compounds for the 
experiment were original from the sample solution rather than from SPE tubes, etc. The 
eluted extracts were evaporated after separation to remove MeOH, then each fraction 
(including negative control fraction) underwent another round of experiments to find the 
active fractions for each assay. Bio-compounds in active fractions were further identified and 
sequenced by Liquid Chromatography with tandem mass spectrometry (LC-MS/MS). 
 
2.4.2 Pronase digestion 
To further confirm if the active compounds were peptides, a pronase digestion experiment 
was performed before identification. Pronase is a commercially available mixture of 
proteases isolated from a bacteria Streptomyces griseus, which can effectively digest proteins 
into individual amino acids. Briefly, the pronase powder (EC 3.4.24.4; ~7.0 units/mg protein; 
purchased from Sigma-Aldrich, St. Louis, Mo., U.S.A) was re-suspended in water and 
reacted with BPIH samples (in 0.1M Tris buffer, pH 7.5) (1:10 to 1:1000 pronase: sample 
ratio) (Lomenick et al., 2011). Samples were vortexed for 15 s and incubated overnight at 40  
with agitation at 1400 rpm in thermomixer (Eppendorf, Mississauga, ON). Pronase digestion 
was stopped by heating at 80  for 20 min, then the samples were cooled down to room 
temperature and filtered through a 3K filter (Pall, Mississauga, ON) to remove pronase. 
Samples after pronase digestion were tested again for the experiments discussed above. Loss 





2.4.3 LC-MS/MS identification 
The MS data were obtained using a Q-Exactive Quadrupole Orbitrap mass spectrometer 
system (Thermo Fisher Scientific, Waltham, MA, U.S.A), that is coupled to an Agilent 1290 
high-performance liquid chromatography (HPLC) system with a Zorbax Eclipse Plus RRHD 
C18 column (2.1 x 50 mm,1.8 µm; Agilent) maintained at 35 °C. The mobile phase was 
water with 0.1 % formic acid (A), and acetonitrile with 0.1 % formic acid (B) (Optima grade, 
Fisher Scientific, Fair Lawn, NJ, U.S.A). Mobile phase B was held at 0 % for 0.5 min, before 
being increased to 100 % over 3 min. Mobile phase B was held at 100 % for 1.5 min, before 
returning to 0 % B over 0.5 min. Injections of 5 L were used with a flow rate of 0.3 mL/min. 
The following conditions were used for positive HESI: capillary voltage, 4.3 kV; capillary 
temperature, 400 °C; sheath gas, 25 units; auxiliary gas, 15 units; probe heater temperature, 
450 °C; SLens RF level, 65. A top 5, data dependent acquisition (DDA) method was used 
that involved a full MS scan at 70,000 resolution over a 150 to 1800 m/z; automatic gain 
control (AGC) target and maximum injection time (max IT) were 1×106 and 256 ms 
respectively. The top 5 most intense ions were selected for MS/MS at a resolution of 17,500, 
AGC target and maximum injection time of 5×106 and 64 ms, respectively. The isolation 
window and normalized collision energy was 1.2 m/z and 34, respectively. 
 
2.5 Statistical Analysis 
All experiments were performed in triplicate with a minimum of three biological replicates. 
Data for each experiment were subjected to analysis by one-way analyses of variance 
(ANOVA) using Minitab (ver. 18.1, Minitab Inc., State College, PA.), and means were 





Chapter 3: Results 
3.1 Qualification and quantification for the BPIH 
3.1.1 Sanilac, SARC1, SMARC1-PN1 and SMARC1N-PN1 
protein profiles before and after simulation of 
gastrointestinal digestion 
The protein profiles of the Sanilac, SARC1, SMARC1-PN1 and SMARC1N-PN1 were 
analyzed by SDS-PAGE of protein extract from mature seeds. Figure 3 - 1 (left) shows the 
protein profiles for the different common bean varieties. Phaseolin comprises 2 to 6 
polypeptides with molecular weights ranging from 43 to 54 kDa (Osborn and Brown, 1988). 
Sanilac showed two major bands near 55 kDa corresponding to phaseolin. SARC1 also 
showed two bands near 55 kDa that correspond to phaseolin, but less than the commercial 
parent Sanilac. As expected, these bands were absent from the phaseolin-deficient lines, 
SMARC1-PN1 and SMARC1N-PN1. Arcelin, a 36 kDa protein, is another seed storage 
protein mostly found in wild bean varieties (Osborn et al., 1986; Taylor et al., 2008). A 
prominent band showed in SARC1 and SMARC1-PN1 above 35 kDa that corresponds to the 
arcelin-1, which is in accordance with the literature that introgression of the arcelin-1 allele 
can lower phaseolin content (Romero-Andreas et al., 1986). This band was absent in 
SMARC1N-PN1. Lectins are seed storage proteins found in common bean, with molecular 
weights between 27 and 37 kDa (Sathe, 2002). Sanilac, SARC1 and SMARC1-PN1 showed 
two bands correspond to lectins in a range of 25 and 35 kDa, with the band near 35 kDa 
appearing prominently. These two bands were also absent in line SMARC1N-PN1. As seen 
in Figure 3 - 1 (right), almost all proteins were reduced for all four varieties after pepsin and 






Figure 3 - 1: Protein profiles for different common bean varieties before and after 
simulated digestion. Extracts before (undigested) and after (post pepsin/pancreatin) protease 
treatment were resolved by 10% SDS-PAGE gel followed by staining with Coomassie Blue. 





3.1.2 Quantification of digested peptides of the Sanilac, SARC1, 
SMARC1-PN1 and SMARC1N-PN1 
3.1.2.1 The molecular mass peptide profiles of the Sanilac, 
SARC1, SMARC1-PN1 and SMARC1N-PN1 hydrolysates 
MALDI TOF/TOF analysis was performed on the molecular mass peptides of digested 
protein extracts from Sanilac, SARC1, SMARC1-PN1 and SMARC1N-PN1. Table 3 - 1 
shows the molecular mass profiles range from 600 to 3000 Da for the different common bean 
varieties. In Sanilac BPIH, there were 56.58% peptides whose molecular mass range from 
600 to 1000 Da (35.59% with 600 to 800 Da and 20.99% with 800 to 1000 Da). For SARC1 
and SMARC1-PN1 BPIH, the 600 to 1000 Da peptides represented 84.21% (65.76% + 
18.45%) and 82.61% (64.86% + 17.75%), respectively. SMARC1N-PN1 BPIH had 51.10% 
peptides ranging from 600 to 800 Da and 18.43% from 800 to 1000 Da. The molecular mass 
profiles confirmed that the proteins were digested to small peptides, and over 50% of them 
ranged from 600-1000 Da for all four varieties, with the molecular mass range from 600 to 
3000 Da. 
 
Table 3 - 1: The percentage (%) of hydrolysed peptides under different molecular mass 






(Mean ± SD) 
SARC1  
(Mean ± SD) 
SMARC1-PN1 
(Mean ± SD) 
SMARC1N-PN1 
(Mean ± SD) 
600-800 33.96 ± 1.49 28.16 ± 3.60 32.59 ± 1.89 46.91 ± 5.94 
800-1000 22.57 ± 1.50 26.94 ± 2.66 21.72 ± 1.44 19.53 ± 1.56 
1000-1200 13.35 ± 1.61 17.09 ± 0.96 19.81 ± 1.62 12.26 ± 3.76 
1200-1400 7.71 ± 1.37 7.08 ± 1.94 9.64 ± 4.79 7.20 ± 0.72 
1400-1600 6.91 ± 1.23 7.59 ± 2.10 6.81 ± 1.30 4.96 ± 0.05 
1600-1800 5.75 ± 1.75 5.09 ± 2.66 3.70 ± 0.18 2.80 ± 0.17 
1800-2000 5.34 ± 0.70 4.51 ± 0.79 4.12 ± 2.59 4.34 ± 0.44 




3.1.2.2 Quantification of the Sanilac, SARC1, SMARC1-PN1 
and SMARC1N-PN1 BPIH 
Since we used alkaline extraction and acid precipitation of common bean proteins in this 
project, phenolic compounds, lipids, carbohydrates, and other substances precipitated at 
lower pH values could affect the purity of the proteins and ultimately concentration of the 
peptides in BPIH extracts (Li et al., 2014). In this case, the quantification of the digested 
Sanilac, SARC1, SMARC1-PN1 and SMARC1N-PN1 peptides was analyzed by a PierceTM 
Quantitative Colorimetric Peptide Assay. For Sanilac BPIH, there was 431.6 g/mL peptides 
per 1 mg/mL freeze-dry BPIH extract. SARC1 had 409.4 g/mL peptides per 1000 g /mL 
freeze-dry BPIH extract. SMARC1-PN1 and SMARC1N-PN1 had 436.2 g/mL and 408.6 
g/mL peptides per 1 mg/mL freeze-dry BPIH extract, respectively. The quantification of 
peptides for all four varieties were approximately 40 - 45% of the BPIH extracts (Table 3 - 2).
  
Table 3 - 2: The peptide concentration in 1 mg/mL extract for Sanilac, SARC1, 
SMARC1-PN1 and SMARC1N-PN1. N = 3. Values are expressed in percentage. 
Genotype Conc. of extracts 
( g /mL) 
Conc. of peptides 
( g /mL) 
(Mean ± SD) 
Percentage of peptides 
(%) 
Sanilac 1000 431.6 ± 31.84 43.16 ± 3.18 
SARC1 1000 409.4 ± 40.86 40.94 ± 4.09 
SMARC1-PN1 1000 436.2 ± 22.26 43.62 ± 2.22 






3.2 Assessment of the predicted bioactivity for the BPIH 
3.2.1 -a -glucosidase enzymes 
Inhibitors for -a -glucosidase enzymes are 
because they inhibit those enzymes which can break down starch into glucose, thereby 
lowering post-meal blood glucose levels (Zhang et al., 2020). Acarbose is a known 
pharmaceutical inhibitor of -amylase and -glucosidase, and is used as positive control (100% 
inhibition) in experiments for calculating the percentage inhibition of these two enzymes. 
(Mojica et al., 2015). Table 3 - 3 revealed that the percentage inhibition of Sanilac BPIH for 
-amylase was relatively low (lower than 6% inhibition compared with acarbose). Moreover, 
despite the increase in BPIH concentration, there was no increase in -amylase inhibition as 
expected.  
 
Table 3 - 3: Effect of different Sanilac BPIH concentration on -amylase enzyme 
inhibition. N = 3. Values are expressed in percentage. 
Samples -amylase inhibition (%) 
(Mean ± SD) 
0.5 mg/mL Sanilac BPIH 5.74 ± 2.08 
1 mg/mL Sanilac BPIH 4.59 ± 1.11 
2 mg/mL Sanilac BPIH 4.20 ± 1.67 
5 mg/mL Sanilac BPIH 5.12 ± 1.57 
10 mg/mL Sanilac BPIH 2.25 ± 1.49 








The Sanilac BPIH made with different cooking time of mature seeds were also measured for 
-amylase inhibition experiment to test if cooking times impacted enzyme inhibition 
properties of BPIH. Sanilac seeds, boiled for 15 min, 30 min and 1 h, were used for making 
the BPIH, followed by enzyme inhibition assays. The result indicated that different cooking 
time had little to no effect on the property of Sanilac BPIH to inhibit -amylase enzyme 
(Table 3 - 4). 
 
Table 3 - 4: Effect of different Sanilac BPIH cooking time (15 min, 30 min, 60 min) on 
-amylase enzyme inhibition. N = 3. Values are expressed in percentage. 
Samples -amylase inhibition (%) 
(Mean ± SD) 
Sanilac BPIH cook for 15 min 5.99 ± 5.77 
Sanilac BPIH cook for 30 min 5.62 ± 3.51 
Sanilac BPIH cook for 60 min 4.79 ± 3.87 






The percentage inhibition of 0.1 mg/mL Sanilac, SARC1, SMARC1-PN1 and SMARC1N-
PN1 BPIH of -amylase enzyme are shown in Table 3 - 5. The data corresponded to average 
percentage inhibition of three technical replicates. It was clear that there was no significant 
-amylase among four common bean varieties (P > 0.05), and 
none of the common bean peptides had more than 10% inhibition of -amylase enzyme 
activity.  
 
Table 3 - 5: Effect of 0.1 mg/mL of four genotypes BPIH (Sanilac, SARC1, SMARC1-
PN1, and SMARC1N-PN1) on -amylase enzyme inhibition. Values are expressed in 
percentage; n =3. P =0.794. 
Samples -amylase inhibition (%) 
(Mean ± SD) 
0.1 mg/mL Sanilac BPIH 7.13  4.94 
0.1 mg/mL SARC1 BPIH 8.78 ± 3.65 
0.1 mg/mL SMARC1-PN1 BPIH 5.08 ± 4.59 
0.1 mg/mL SMARC1N-PN1 BPIH 8.48 ± 7.78 






The percentage inhibition of -glucosidase enzyme for all four cultivars are presented in 
Figure 3 - 2. They correspond to average percentage inhibition of three technical replicates. 
T -glucosidase was relatively low, and none of the common bean varieties 
among the concentrations of BPIH from 0.1 to 1 mg/mL had any significant (P > 0.05) 
inhibition, as well as interaction of cultivars and their BPIH concentration. All samples 
ranged between 0 and 10% inhibition. 
 
Figure 3 - 2: -Glucosidase enzyme response to 0.1 mg/mL Sanilac, SARC1, 
SMARC1-PN1 and SMARC1N-PN1 BPIH. Values are expressed in percentage; n =3. 
 
Thus, common bean protein hydrolysates with the potential to inhibit -a -
glucosidase were not been detected in this project. The average percentage inhibition of 
theses two enzymes by four common bean cultivars with different BPIH were all less than 






























3.2.2 The 3T3-L1 tissue culture 
Obesity is one of the risk factors for type 2 diabetes, and the prevalence of diabetes increases 
significantly among chronically obese people (Al-Goblan et al., 2014). The 3T3-L1 cell line 
was derived from mouse embryos, and is a fibroblast-like cell line used to study adipose 
metabolism (Martinez-Villaluenga et al., 2009). Figure 3 - 3 (left) shows how 3T3-L1 
fibroblasts and mature adipocytes look like, and Figure 3 - 3 (right) demonstrates how lipid 
droplets appear after staining with Oil Red. 






Figure 3 - 3: Pre-adipocytes and mature adipocytes under phase contrast microscope 







Unexpectedly, the inhibition of lipid droplets accumulation was not seen in the mature 3T3-
L1 cell line treated with Sanilac and SMARC1N-PN1 BPIH based on the Oil Red O assay. 
The absorbance for untreated and treated cell cultures was at the same level (around 0.9) 
(Figure 3 - 4), thus indicating that common bean protein hydrolysates do not inhibit lipid 
growth in culture. Therefore, no further research was performed in this area of my project.  
 
 
Figure 3 - 4: Absorbance of untreated and treated 3T3-L1 cell cultures with Sanilac and 



























3.2.3 Antioxidant capacity 
3.2.3.1 Oxygen radical absorbance capacity (fluorescein-
ORAC) assay  
The ORAC-FL assay is based on a hydrogen atom transfer reaction, related to radical chain-
breaking capacity of antioxidants (Prior, 2015). The unit of ORAC value was expressed as 
micromoles Trolox equivalents per gram of dry BPIH extracts ( mol TE/g). Data in Table 3 - 
6 revealed that 0.1 mg/mL dry BPIH extract from SMARC1N-PN1 had the significantly 
highest antioxidant capacity (P < 0.05) among the four cooked bean varieties (up to 362.73 
dry BPIH extract), followed by SARC1, SMARC1-PN1, and Sanilac. The 
difference in ORAC value between SMARC1-PN1 and SARC1 was not significant (P > 
0.05); the same was true between SMARC1-PN1 and Sanilac. 
 
Table 3 - 6: The Net AUC corresponding to the different varieties of common bean and 
the calculated Trolox equivalents concentration and ORAC value, n=6.  








(Mean ± SD) 
ORACFL ( mol 
TE/g) 
(Mean ± SD) 
Sanilac  0.1 19.87 ± 1.61  25.91 ± 2.45 259.10 ± 24.50 c 
SARC1 0.1 22.33 ± 0.91 29.94 ± 1.10 299.42 ± 10.95 b 
SMARC1-PN1 0.1 21.66 ± 1.59 28.79 ± 2.60   287.87 ± 26.00 bc 
SMARC1N-PN1 0.1 26.02 ± 1.25 36.27 ± 1.68 362.73  16.81 a 
Means followed by the same letter within columns are not significantly different according to T-protected HSD 






3.2.3.2 Ferric reducing/antioxidant power (FRAP) assay 
The FRAP assay is based on single electron transfer reaction, related to the capacity of 
antioxidants to reduce an oxidant, concomitantly with a color change (Huang et al., 2005). 
The unit of FRAP value was expressed as micromoles ascorbic acid equivalents per gram of 
dry BPIH extracts (  AAE/g). The 30 mg/mL dry BPIH extract from SARC1 BPIH 
recorded the highest FRAP value (up to 6.91 AAE/g dry BPIH extract), followed by 
Sanilac, SMARC1-PN1 and SMARC1N-PN1. The difference in FRAP value between 
SARC1 and Sanilac was not significant (P > 0.05); however, the FRAP value decreased 
significantly (P<0.05) in SMARC1-PN1 and SMARC1N-PN1 (Table 3 - 7).  
 
Table 3 - 7: The calculated ascorbic acid equivalents concentration and FRAP value, 
n=3.  
Variety Conc. (mg/mL) Ascorbic acid 
Equivalents Conc. 
 
(Mean ± SD) 
AAE/g) 
(Mean ± SD) 
Sanilac  30 195.26 ± 0.23 6.51 ± 0.23 a 
SARC1 30 207.22 ± 1.38 6.91 ± 0.05 a 
SMARC1-PN1 30 177.99 ± 2.52 5.93 ± 0.08 b 
SMARC1N-PN1 30 162.49 ± 9.02 5.42 ± 0.30 c 
Means followed by the same letter within columns are not significantly different according to T-protected HSD 






3.2.4 DPP-IV inhibition activity 
The IC50 value indicates the half-inhibition concentration, which refers to the drug or 
inhibitor concentration required to inhibit half of a specific biological or biochemical process 
(Swinney, 2011). For the DPP-IV inhibition experiment, the lower the IC50 value, the 
stronger the inhibition property of the common bean derived BPIH. Figure 3 - 6 indicates 
that SMARC1N-PN1 BPIH had the lowest IC50 value among the four varieties (0.86 mg/mL 
freeze-dry BPIH extract), which means it had the strongest potential to block the DPP-IV 







Figure 3 - 5: IC50 curves corresponding to the different varieties of common bean BPIH 





3.2.5 Antimicrobial ability 
After overnight incubation, the status of bacterium growth was observed and recorded. The 
circular area in each plate means zone of inhibition where bacteria can not grow. Larger area 
and darker color of zone of inhibition represents for the better antimicrobial capability of the 
samples. Figure 3 - 6 indicates that the BPIH for all four varieties possessed antimicrobial 
activity against B. subtilis and S. aureus, some activity against E. coli and K. 
pneumoniaaureus, little to no activity against P. aeruginosa, and no activity against E. 
carotovora and S. heidelberg. Gram-positive bacteria, B. subtilis and S. aureus, appear to be 
sensitive to killing. 
   
Bacillus subtilis Staphylococcus aureus Escherichia coli 
   
Klebsiella pneumoniae Pseudomonas aeruginosa Erwinia carotovora 
 
  
Salmonella heidelberg   
Figure 3 - 6: Antimicrobial susceptibility test results for all common bean BPIH with 7 
bacterial cultures. Bacterial cultures including Bacillus subtilis, Staphylococcus aureus, 
Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Erwinia carotovora, and 
Salmonella Heidelberg. 1 = Sanilac; 2 = SMARC1-PN1; 3 = SARC1; 4 = SMARC1N-PN1; 




3.3 Bioactive compounds identification 
3.3.1 Bioactive compounds identification for DPP-IV inhibition 
3.3.1.1 DPP-IV inhibition by solid-phase extraction (SPE) 
fractions 
Since it had the highest DPP-IV inhibition property (Figure 3 - 5), the SMARC1N-PN1 
BPIH was used for testing whether the active compounds would elute using MeOH from 
Bond Elut Plexa SPE columns. Figure 3 - 7 confirmed that almost all active compounds in 




Figure 3 - 7: The DPP-IV inhibitory activity of SMARC1N-PN1 BPIH and its fractions 
that eluted by 0% and 100% MeOH. BPIH was loaded into Bond Elut Plexa SPE column, 
n=3. Flow-through = flow-through from the SPE column; 0% MeOH = solution with 




































The SMARC1N-PN1 BPIH loaded into a SPE column was then eluted by increasing 
concentrations of MeOH with 25% interval from 0% to 100%. Data in Figure 3 - 8 indicate 
that almost all active compounds in SMARC1N-PN1 BPIH which have inhibitory effect on 
DPP-IV enzyme were eluted by 75% MeOH, which means the active compounds were 
located between the 50% and 75% MeOH fraction. 
 
 
Figure 3 - 8: The DPP-IV inhibition results for SMARC1N-PN1 BPIH and its fractions 
that eluted by 0% to 100% MeOH with 25% interval. BPIH was loaded into Bond Elut 
Plexa SPE column, n=3. Flow-through = flow-through from the SPE column; 0% MeOH = 
solution with compounds eluted by water; 25-100% MeOH = solution with compounds 
































The SMARC1N-PN1 BPIH was further eluted from SPE column by MeOH, with 10% 
interval between 50% to 80%, and 100% MeOH. Data in Figure 3 - 9 indicate that the 
majority of active compounds in SMARC1N-PN1 BPIH which have inhibitory effect on 
DPP-IV enzyme were eluted by 70% MeOH, which means the active compounds were 
located between the 60% and 70% MeOH fraction. Active compounds that could inhibit 
DPP-IV enzyme were also found in 80% MeOH fraction. Previous results showed that the 
active compounds were located between the 50% and 75% MeOH fraction (Figure 3 - 8), 
revealing that the active compounds are eluted between 60 to 75% MeOH fraction.  
 
 
Figure 3 - 9: The DPP-IV inhibition results for SMARC1N-PN1 BPIH and its fractions 
that eluted by 0%, 50%, 60%, 70%, 80, and 100% MeOH. BPIH was loaded into Bond 
Elut Plexa SPE column, n=3. Flow-through = flow-through from the SPE column; 0% MeOH 
= solution with compounds eluted by water; 50-100% MeOH = solution with compounds 




































The negative control was water containing the same concentration of pepsin and pancreatin 
as BPIH samples and incubated under the identical conditions. The inhibitory effect of 
negative control solution loaded into a Bond Elut Plexa SPE column and eluted by different 
concentrations of MeOH on DPP-IV enzyme is shown in Figure 3 - 10. The results 
confirmed that all active compounds for the DPP-IV inhibition experiment were originally 
from the SMARC1N-PN1 BPIH solution rather than from the SPE column, pepsin and 
pancreatin, or liquids used for elution, etc. 
 
Figure 3 - 10: The DPP-IV inhibition results for negative control and its fractions that 
eluted by 0%, 50%, 60%, 70%, 80, and 100% MeOH. Negative control was loaded into 
Bond Elut Plexa SPE column and n=3. Flow-through = flow-through from the SPE column; 0% 
MeOH = solution with compounds eluted by water; 50-100% MeOH = solution with 





























The BPIH of Sanilac, SARC1, and SMARC1-PN1 and SMARC1N-PN1 were then SPE 
fractionated at the same time under the identical environment and this confirmed that, like the 
results of SMARC1N-PN1 shown in Figure 3 - 7 and Figure 3 - 8, the majority of active 
compounds were in 50  75% MeOH for all varieties. The BPIH of four varieties were 
further eluted by 0% MeOH, 10% interval between 50% to 80% MeOH, and 100% MeOH. 
Figure 3 - 11 shows that the majority of active compounds in BPIH of all four cultivars, 
exhibiting DPP-IV inhibition activity, were eluted by 80% MeOH, which means the active 
compounds were located between the 70% and 80% MeOH fraction. SPE is a pre-separated 
method of active compounds, which means it is a rough separation of active compounds 
compare with other accurate separation methods like HPLC. The result in Figure 3 - 11 
shows a little bit different elution pattern for SMARC1N-PN1 than in Figure 3 - 8 and 
Figure 3 - 9 (active compounds for SMARC1N-PN1 were located between the 60% and 75% 
MeOH fraction), which possibly due to the instrument error. Based on above mentioned three 
figures, the active compounds should be eluted near the 70% MeOH fraction.  
 
 
Figure 3 - 11: The DPP-IV inhibition results for Sanilac, SARC1, SMARC1-PN1, 
SMARC1N-PN1 BPIH, and their fractions that eluted by 0%, 50%, 60%, 70%, 80, and 
100% MeOH. BPIH were loaded into Bond Elut Plexa SPE column, n=3. Flow-through = 
flow-through from the SPE column; 0% MeOH = solution with compounds eluted by water; 



















Fractions for different common bean cultivars




The peptide quantification of each fraction for all four common bean cultivars was tested and 
presented in Table 3 - 8. The data demonstrated that most peptides remained in the flow-
through solution, and the eluted peptides were detected in the lower %MeOH fractions (0% 
and 50% MeOH fractions), but not in the fractions containing active compounds which 
inhibit DPP-IV enzyme activity (70% and 80% MeOH fractions). Based on these findings, it 
unlikely that the active compounds are peptides. 
 
Table 3 - 8: The peptide concentration -PN1, 




























































































3.3.1.2 Pronase digestion of common bean BPIH 
To further determine if the active compounds which inhibited DPP-IV enzyme were peptides, 
Pronase was used to digest the BPIH of four common bean cultivars before identification. 
Based on Lomenick et al. (2011), Pronase is composed of highly reactive enzymes that can 
digest almost all proteins completely within the Pronase-protein ratio range of 1: 100 to 1: 
10,000. Figure 3 - 12 depicts the result for the DPP-IV inhibition assay of Sanilac BPIH 
itself and with Pronase added at ratios from 1:10 to 1:1000. Interestingly, regardless of how 
much Pronase was added, the ability of Sanilac BPIH to block DPP-IV enzyme activity 
remained at a similar level. 
 
 
Figure 3 - 12: DPP-IV inhibition results for Sanilac BPIH itself and after treatment with 
Pronase at ratios ranging from 1: 10 to 1:1000, n= 3.  
 
   


























BPIH from all four cultivars were also treated with Pronase at ratio 1: 500. DPP-IV inhibition 
results are presented in Figure 3 - 13 indicating that BPIH-mediated DPP-IV inhibition was 
still detectable after Pronase digestion. These findings further confirm that the active 
compounds were probably not peptides. 
 
 
Figure 3 - 13: The DPP-IV inhibition results for Sanilac, SARC1, SMARC1-PN1 and 































3.3.1.3 Identification and putative chemical formula of active 
compounds that inhibit DPP-IV enzyme by LC-MS/MS 
Since the cultivar extracts showed a similar pattern of elution (Figure 3 - 11), and 
SMARC1N-PN1 had the highest DPP-IV inhibition property (Figure 3 - 5), this cultivar was 
chosen to identify the active compounds that inhibit DPP-IV enzyme. The HPLC results 
demonstrated that 1223 compounds in total were found in SMARC1N-PN1 BPIH but 821 
were removed because they did not appear in any of the fractions analyzed. It is possible that 
some compounds either remained in the flow-through solution, did not survive the dry down 
step, or remained bound to the SPE column. Since the SMARC1N-PN1 BPIH was much 
more complex than an individual fraction, some compounds might have been observed in a 
fraction but may be below the limit of detection or at low levels in the SMARC1N-PN1 BPIH, 
so they were retained. The rest of the 402 compounds were analysed with 42 compounds 
exhibiting maximum peak areas in the 70% and 80% MeOH fractions, and 32 of them were 









Table 3 - 9: Compounds with maximum peak areas in 70% and 80% MeOH fraction. 
Compounds highlighted in yellow were only present in 70% and 80% MeOH. Features are 
arranged by the size of peak area from top to bottom. 
Row 
ID m/z RT (min) Crude (-) Crude (+) 50 (+) 60 (+) 70 (+) 80 (+) 100 (+) 
1 594.4479 4.73 0 0 0 0 6.00E+09 0 0 
2 566.4178 4.94 0 0 0 0 5.66E+09 0 0 
3 780.5521 4.89 0 0 0 0 5.47E+09 0 0 
4 524.3718 5.06 0 1.61E+10 0 2.19E+09 3.61E+09 0 0 
5 567.4227 4.94 0 0 0 0 2.60E+09 0 0 
6 588.4008 5.18 0 0 0 0 1.94E+09 0 0 
7 781.5562 4.89 0 0 0 0 1.73E+09 0 0 
8 595.4525 4.49 0 0 0 0 1.57E+09 0 0 
9 802.5333 5.19 0 0 0 0 1.25E+09 0 0 
10 616.4301 5.19 0 0 0 0 7.20E+08 0 0 
11 803.5369 5.19 0 0 0 0 6.17E+08 0 0 
12 546.3523 5.19 0 3.15E+09 0 1.48E+08 6.11E+08 0 0 
13 525.3755 5.05 0 4.15E+09 0 1.50E+08 4.36E+08 0 0 
14 582.3757 4.44 0 0 0 0 3.39E+08 0 0 
15 907.5774 4.5 0 1.21E+09 9.91E+07 2.68E+08 3.14E+08 0 0 
16 782.562 4.89 0 0 0 0 2.91E+08 0 0 
17 313.2739 4.51 0 0 0 0 2.44E+08 0 0 
18 754.5376 4.73 0 0 0 0 2.33E+08 0 0 
19 596.4564 4.73 0 0 0 0 2.32E+08 0 0 
20 617.433 5.18 0 0 0 0 2.04E+08 0 0 
21 547.3561 5.19 0 8.02E+08 0 0 1.61E+08 0 0 
22 482.3241 4.97 0 0 0 0 1.48E+08 0 0 
23 545.3394 4.66 0 0 0 1.33E+08 1.41E+08 0 0 
24 485.2867 4.07 0 0 0 0 1.40E+08 0 0 
25 908.5829 4.5 0 5.45E+08 0 1.21E+08 1.27E+08 0 0 
26 502.29 4.62 0 0 0 0 1.08E+08 0 0 
27 456.2991 4.5 0 2.97E+08 4.08E+07 7.09E+07 9.13E+07 0 0 
28 526.3766 5.08 0 0 0 0 5.18E+07 0 0 
29 1115.7997 4.64 0 0 0 0 5.17E+07 0 0 
30 755.5411 4.73 0 0 0 0 4.75E+07 0 0 
31 1089.7852 4.58 0 0 0 0 4.35E+07 0 0 
32 436.2827 4.51 0 9.80E+07 0 0 3.78E+07 0 0 
33 1019.701 4.51 0 0 0 0 3.49E+07 0 0 
34 1116.7996 4.64 0 0 0 0 3.25E+07 0 0 
35 399.2522 4.8 1.52E+09 0 0 0 3.11E+07 0 2.93E+07 
36 483.328 4.97 0 0 0 0 2.54E+07 0 0 
37 353.2686 4.99 0 3.23E+08 0 0 2.29E+07 0 0 
38 1090.7841 4.58 0 0 0 0 2.00E+07 0 0 
39 804.5453 5.19 0 0 0 0 2.87E+07 2.75E+09 0 
40 596.3909 4.54 0 0 0 0 0 1.65E+09 0 
41 230.2477 3.92 0 0 0 0 0 7.57E+07 0 




According to the LC-MS/MS analysis, the active compounds in 70% and 80% MeOH 
fractions that blocked the DPP-IV enzyme were identified as lipid compounds. There were 32 
compounds identified in total, while 2 of them were considered as contaminants (Row ID 28 
and 35) by the chemist Dr. Justin Renaud based on the criteria that they were either detected 
in the negative control [Crude (-)] or as an isotope of other compounds which detected in the 
Crude (-). There were 8 of 32 compounds indicated as potential active compounds that inhibit 
DPP-IV enzyme belonging to lipid classes: monoacylglycerol (MG), 
phosphatidylethanolamine (PE), phosphatidylglycerol (PG) and 5 phosphatidylcholines (PC). 




Table 3 - 10. The phosphatidylcholines seem more abundant than other lipid compounds 
based on peak intensity in Table 3 - 9 (Row ID 1, 2, 3, 14, 18), and the monoacylglycerol 
may be potentially important because it was only detected in the 70% MeOH fraction and 
BPIH solution. There were 2 additional compounds belonging to phosphatidylcholine based 
on MS/MS fragmentation, but the formula could not be identified. Others represented either 
the isotope or sodiated form of these compounds. With Mass Spec alone, it is hard to identify 
the structure for any of these compounds accurately. In future studies, it would be of interest 
to perform nuclear magnetic resonance to identify these potential active compounds, then 
obtain them from a commercial manufacturer or isolate and purify from common bean BPIH, 






Table 3 - 10: The putative formula and possible structure of active compounds derived 
from SMARC1N-PN1 that might inhibit the DPP-IV enzyme. 
Putative 
formula 





























































3.3.2 Solid-phase extraction (SPE) fraction action for 
antimicrobial property 
According to Figure 3 - 6, the antimicrobial capacity of BPIHs derived from the four 
cultivars, B. subtilis exhibited the highest susceptibility compared to the other 6 bacteria, so it 
was the only one chosen for the active compounds identification. The steps of SPE 
fractionation for the separation of the antimicrobial active compounds in BPIH were the same 
as those for the separation of active compounds inhibiting DPP-IV enzyme. Sanilac, SARC1, 
SMARC1-PN1 and SMARC1N-PN1 BPIH were flowed through the Bond Elut Plexa SPE 
column and eluted by 0% and 100% MeOH. The result is presented in Figure 3 - 14. Most 
active compounds in Sanilac, SARC1, SMARC1-PN1 and SMARC1N-PN1 BPIH which had 
antimicrobial properties were eluted by 100% MeOH, while there were still some active 
compounds that remained in the flow-through solution. 
  
B.subtilis affected by BPIH (4 cultivars) B.subtilis affected by flow-through solution (4 
cultivars) 
  
B.subtilis affected by 0% MeOH (4 cultivars) B.subtilis affected by 100% MeOH (4 cultivars) 
Figure 3 - 14: Antimicrobial susceptibility test result for Sanilac, SARC1, SMARC1-
PN1, SMARC1N-PN1 BPIH, and their SPE fractions to inhibit B. subtilis. 1 = Sanilac; 2 
= SARC1; 3 = SMARC1-PN1; 4 = SMARC1N-PN1; 5 = Positive control (Penicillin); 6 = 




The peptide quantification of each fraction for all four common bean cultivars was also tested 
and presented in Table 3 - 11. The data demonstrated that most peptides remained in the 
flow-through solution, but not in the fractions containing active compounds which had 
antimicrobial property (100% MeOH fractions). These findings indicate that the 
antimicrobial active compounds were also probably not peptides. 
 
Table 3 - 11: 
SMARC1-PN1 and SMARC1N-PN1 BPIH and their fractions. n=3. 
BPIH (Mean ± SD) 
Flow-through 
(Mean ± SD) 
0% MeOH 
(Mean ± SD) 
100%MeOH 
(Mean ± SD) 
Sanilac 4850.0 ± 558.0 4720 ± 30.0 471.5 ± 23.18 208.1 ± 6.1 
SARC1 4338.0 ± 174.9 3891 ± 35.0 433.34 ± 10.2 206.66 ±24.2 
SMARC1-PN1 4667.1 ± 38.0 4218 ± 33.9 459.93 ± 20.0 226.9 ± 11.3 
SMARC1N-PN1 5923.5 ± 203.6 4588 ± 78.2 408.2 ± 8.1 484.8 ± 29.0 
 
The Sanilac, SARC1, SMARC1-PN1 and SMARC1N-PN1 BPIH were then loaded onto the 
Bond Elut Plexa SPE column and eluted by MeOH with 0% to 100% in 25% increments. 
Figure 3 - 15 indicated that active compounds which had some antimicrobial properties were 
found in in plates treated with 50, 75 and 100% MeOH fraction, whereas plates treated with 0% 
and 25% MeOH fractions exhibited no antimicrobial effects. The results suggested that active 






B.subtilis affected by BPIH (4 
varieties) 
B.subtilis affected by flow-through 
solution (4 varieties) 
  
B.subtilis affected by 0% MeOH (4 
varieties) 
B.subtilis affected by 25% MeOH 
(4 varieties) 
 
   
B.subtilis affected by 50% 
MeOH (4 varieties) 
B.subtilis affected by 75% 
MeOH (4 varieties) 
B.subtilis affected by 100% 
MeOH (4 varieties) 
Figure 3 - 15: Antimicrobial susceptibility test result for Sanilac, SARC1, SMARC1-
PN1, SMARC1N-PN1 BPIH, and their fractions that eluted with 0% MeOH to 100% 
MeOH at 25% increments to inhibit B. subtilis. BPIH were loaded into Bond Elut Plexa 
SPE column. 1 = Sanilac; 2 = SARC1; 3 = SMARC1-PN1; 4 = SMARC1N-PN1; 5 = 






3.3.3 Solid-phase extraction (SPE) fraction action for antioxidant 
capacity 
Although the results of different antioxidant experiments cannot be compared since the 
different methods involved different chemistries ((Huang et al., 2005; Prior, 2015), it was 
clear that the experimental principle for the ORAC assay were more similar to how human 
body detoxify ROS than those of FRAP assay. Moreover, the FRAP values were relatively 
low, which means that the color change was not easily observed (Table 3 - 6 and Table 3 - 7). 
So, the ORAC assay was the one chosen for further active compounds identification. 
According to Table 3 - 6, the SMARC1N-PN1 BPIH exhibited the highest antioxidant 
capacity, so this cultivar was further assessed to determine if the active compounds would 
elute by 0% and 100% MeOH following SPE fractionation with Bond Elut Plexa SPE column. 
However, the results suggested that most active compounds in SMARC1N-PN1 BPIH with 
antioxidant capacity remained in the flow-through solution (Table 3 - 12). 
 
Table 3 - 12: The Net AUC and Trolox equivalents concentration corresponding to the 
SMARC1N-PN1 BPIH and its fractions that eluted with 0% and 100% MeOH. BPIH 
was loaded onto Bond Elut Plexa SPE column; n=3.  
Fractions Net AUC 
(Mean ± SD) 
Trolox Equivalents Conc. ( mol/L) 
(Mean ± SD) 
SMARC1N-PN1 BPIH 46.63 ± 1.71 88.71 ± 3.45 
Flow-through 35.05 ± 1.05 65.28 ± 2.49 
0% MeOH 6.80 ± 0.57 0.14 ± 1.32 






The negative control consisted of water containing the same concentration of pepsin and 
pancreatin as the BPIH samples and incubated under identical conditions. The antioxidant 
capacity of the negative control loaded into Bond Elut Plexa SPE column and eluted by 
different concentrations of MeOH is shown in Table 3 - 13. The result confirmed that all 
active compounds for the antioxidant experiment originated from the SMARC1N-PN1 BPIH 
solution rather than from the SPE column, pepsin and pancreatin, etc. 
 
Table 3 - 13: The Net AUC and Trolox equivalents concentration corresponding to the 
negative control and its fractions that eluted with 0% and 100% MeOH. BPIH was 
loaded into Bond Elut Plexa SPE column, n = 3. 
Fractions Net AUC 
(Mean ± SD) 
Trolox Equivalents Conc. ( mol/L) 
(Mean ± SD) 
Negative control 9.82 ± 1.14 12.17 ± 2.23 
Flow-through 5.90 ± 0.53 6.34 ± 0.78 
0% MeOH 2.70 ± 1.39 1.58 ± 0.63 





In order to separate the active antioxidant compounds of SMARC1N-PN1 BPIH that 
remained in the flow-through solution, an additional C18 SPE column, which is specific for 
peptide separation was used. The previously collected solution flowing through the Bond Elut 
Plexa SPE column was loaded again into the C18 column and eluted with ACN + 0.1% TFA 
instead of MeOH. Table 3 - 14 revealed that active antioxidant compounds in SMARC1N-
PN1 BPIH which were loaded into the Bond Elut Plexa SPE column but remained in the 
flow-through solution were eluted and separated by the C18 column with 0% and 100% ACN 
+ 0.1%TFA. 
 
Table 3 - 14: The Net AUC and Trolox equivalents concentration corresponding to the 
SMARC1N-PN1 BPIH and its fractions; n = 3.  
Fractions Net AUC 
(Mean ± SD) 
Trolox Equivalents Conc. ( mol/L) 
(Mean ± SD) 
SMARC1N-PN1 BPIH 48.09 ± 0.77 87.01 ±1.50 
Bond Elut Plexa flow-through 31.76 ± 1.60 55.08 ± 3.13 
C18 flow-through 6.75 ± 0.98 6.18 ± 1.91 
0% ACN + 0.1%TFA  12.09 ± 0.03 16.61 ± 0.05 






The previously collected solution flowing through the Bond Elut Plexa SPE column for 
Sanilac, SARC1, SMARC1-PN1 and SMARC1N-PN1 BPIH was reloaded into the C18 
column and eluted with 25% increments of ACN + 0.1% TFA. As shown in Table 3 - 
15, active compounds with antioxidant activity in all four genotypes were detected in the 
fraction eluted with 0% and 25% ACN + 0.1%TFA. For Sanilac and SMARC1-PN1, the 
active antioxidant compounds were also detected in the C18 flow-through fraction. No 
antioxidant compounds were found in higher ACN concentration fractions for all four 
varieties. 
 
Table 3 - 15: The Net AUC corresponding to the Sanilac, SARC1, SMARC1-PN1, 




































































































The peptide quantification of each fraction for all four common bean caltivars were tested 
and presented in Table 3 - 16. Most peptides were eluted by 0% or 25% ACN + 0.1% TFA, 
and contained active compounds which had antioxidant capacity. Moreover, the peptide 
concentration appeared to have a positive relationship with the antioxidant capacity (Table 3 
- 15), suggesting that the active antioxidant compounds in the four common bean varieties 
were likely derived from peptides. 
Table 3 - 16: 
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Chapter 4: Discussion 
4.1 Evaluate the benefits of common bean 
4.1.1 Peptide quality of the common bean 
The primary purpose of this project was to evaluate if peptides derived from cooked common 
bean after exposure to conditions mimicking human digestion, had antioxidant capacity, 
DPP-IV enzyme inhibition, -a -glucosidase inhibition, antimicrobial, and anti-
lipogenic properties, and to identify any bioactive peptides. SDS-PAGE is a common and 
effective way to separate proteins based on their molecular weight and electrophoretic 
mobility. As expected, almost all proteins were digested into small peptides (<10 kDa) for 
four cultivars after pepsin and pancreatin digestion, based on the SDS-PAGE results of the 
protein profiles for the digested beans (Figure 3 - 1). Table 3 - 2 revealed that at least 40% of 
the substances in the BPIH solution were peptides. The molecular mass profiles obtained 
from MALDI-TOF/TOF further confirmed that the proteins were digested to small peptides, 
and over 50% of them were in the molecular mass range from 600-1000 Da for the four 
cultivar varieties (Table 3 - 1). According to Montoya et al. (2008), even though the 
nutritional value of common bean protein is low due to poor digestibility, thermal treatment 
can denature the proteins, breaking the structure and making them more open, 
thereby increasing the exposure of hydrophobic residues. This structural modification allows 
gastrointestinal enzymes to break the proteins down more thoroughly into peptides by 
reaching protein sites that the enzymes cannot naturally access, thereby increasing the 
digestibility of common bean, and producing more small bioactive peptides that the human 
body can absorb (Nosworthy et al., 2018). 
 
4.1.2 Evaluation of the non-nutritional values of common bean 
4.1.2.1 Antioxidant capacity of common bean peptides 
Reactive oxygen species (ROS) are by-product of aerobic metabolism, including peroxides, 
superoxide, and other oxygen-containing free radicals. They are very active because of the 
presence of an unpaired electrons. ROS are produced in large quantities by aerobic organisms 
in the process of aerobic respiration under normal conditions or in the process of innate 




vitro and in vivo studies indicated that common bean protein hydrolysates have antioxidant 
capacity and identified the corresponding peptides (Ariza-Ortega et al., 2014; Betancur-
Ancona et al., 2014; Valdez-Ortiz et al., 2012). Glutathione is an abundant thiol-containing 
tripeptide produced in most organisms that can undergo oxidation and reduction cycles to 
detoxify ROS (Pompella et al., 2003). Since cysteine is the only amino acid that contains 
thiol groups, I would have expected that SMARC1N-PN1, which has a higher combined 
methionine-cysteine content, has higher antioxidant capacity than other cultivars that lack 
sulphur amino acids. As expected, the line SMARC1N-PN1 BPIH had the highest ORAC 
value among other cultivars (Table 3 - 6) since the principle for ORAC assay is the hydrogen 
atom transfer process, which is similar to how glutathione undergoes reversible disulfide 
bond formation to detoxify ROS. However, the BPIH of SMARC1N-PN1 did not perform 
well in the FRAP assay compared with other cultivars (Table 3 - 7). Since the FRAP assay 
analyzed the antioxidant capacity based on the single-electron transfer process, it was 
revealed that SMARC1N-PN1 BPIH was weaker at the donation of an electron to balance 
free radicals compared with Sanilac, SARC1, and SMARC1-PN1 BPIH. Although different 
antioxidant experiments cannot be compared because of the different chemistries of each 
assay, the SMARC1N-PN1 BPIH was considered the best cultivar among four lines against 
free radicals because the chemistry of the ORAC assay was similar to how glutathione 
functions in the human body to neutralize free radicals. 
Many former studies indicated and identified many small bio-peptides of common bean such 
as sequence in in 
Great N bean, (Mojica et al., 2015). Our results presented here also suggest that the active 
compounds in BPIH were probably peptides because the active compounds were all found in 
the fractions that contained a large number of peptides. The concentration of peptides was 
positively related to antioxidant capacity in cultivars, demonstrating that a mixture of 
peptides might work together towards enhanced antioxidant capacity (Table 3 - 15 and Table 
3 - 16).  
 
4.1.2.2 Antimicrobial property of the common bean  
Bacterial drug resistance leads to serious health problems worldwide due to the long-term use 
and the abuse of traditional antibiotics, and it causes at least 700,000 deaths annually 




compounds is attracting increasing attention from scientists worldwide. Because 
antimicrobial peptides are not easily affected by the evolution of bacterial resistance, they are 
considered a promising class of new antibiotics and provide a healthier way to protect the 
human body against pathogens (El Shazely et al., 2020). My results showed that Gram-
positive bacteria, B. subtilis and S. aureus, appear to be sensitive to BPIHs, and all cultivars 
had similar antimicrobial properties for these two bacteria. However, all common bean BPIH 
had little to no inhibitory effect on any kind of gram-negative bacteria (Figure 3 - 6). The 
reason might be related to the different cell wall compositions of gram-positive and gram-
negative bacteria. The cell wall for gram-positive bacteria is simpler than gram-negative 
bacteria, consisting only of teichoic acid and peptidoglycan to encase the cell membrane. In 
contrast, gram-negative bacteria have not only two layers of cell membranes separated by 
periplasmic space composed of murein lipoprotein and peptidoglycan, but also have 
membrane protein and porin in the outer membrane, which is covered by lipid A, O antigen 
and lipopolysaccharide (Beveridge, 1999; Navarre and Schneewind, 1999). In this study, the 
more complex composition of the gram-negative bacteria cell wall seems to protect the 
bacteria from BPIH.  
My results suggest that the active antimicrobial compounds in BPIH were probably not 
peptides because the active compounds were found in fractions containing few peptides 
(Figure 3 - 14 and Table 3 - 11). Since most of the active compounds with antimicrobial 
activity were abundant in plates treated with the 50-100% MeOH fractions (Figure 3 - 15), 
which had similar elution properties to the active compounds exhibiting DPP-IV enzyme 
inhibition (Table 3 - 8 and Figure 3 - 11), we can predict that the active antimicrobial 
compounds might also belong to the lipid class, while few of the literature to date for 
common bean has focused on lipids. To date, many bio-active common bean antimicrobial 
peptides against human pathogens have been identified, such as the peptide sequence 
KTCENLADTFRGPCFATSNC  in King Pole Bean  that can inhibit Candida albicans 
(Wong et al., 2012). There were some articles related to the potential of lipids against 
bacteria. For example, Hinson and Cresswell (2009) and Anand et al. (2012) pointed out that 
some mammalian lipid droplets might be the first line of defense against the invasion of 
pathogens by laced with many antimicrobial proteins. Bosch et al. (2020) further confirmed 
this point by injecting lipopolysaccharide into laboratory mice to simulate bacterial infection 
and isolated lipid droplets from these mice. They found that lipid droplets isolated from mice 




cathelicidin, which made them have better antimicrobial capacity than lipid droplets isolated 
from mice that injected normal saline. Plants lipids, such as fatty acid methyl ester in the 
leaves of sea purslane, S. maritima, and S. monoica (Chandrasekaran et al., 2008; 
Chandrasekaran et al., 2011), fatty acids in the seeds of summer asphodel (Fafal et al., 2016), 
and sterol in the seeds of date palm (Sundar et al., 2017), are reported to have potential 
antimicrobial activity previously. Our result also might indicate lipids found in common bean 
as a potential antibacterial resource against drug resistance. However, information for the 
possible antimicrobial compounds we found in this project is limited concerning the nature of 
the bioactive molecules, so further investigation is needed.  
 
4.1.2.3 DPP-IV inhibition of common bean   
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are 
two important incretins that respond to an increased concentration of glucose in the digestive 
tract lumen to stimulate insulin release, thus lowering blood glucose (Zhong et al., 2013). 
Dipeptidyl peptidase-IV(DPP-IV) rapidly degrades these two incretins, which helps prevent 
the overproduction of insulin and hypoglycemia. To date, the inhibition of the enzyme DPP-
IV is the target of several oral hypoglycemics anti-diabetic medications, including Januvia 
(sitagliptin), Novartis (vidagliptin), Onglyza (saxagliptin), Nesina (alogliptin), etc. (Parmar et 
al., 2012). As outlined in Figure 3 - 5, SMARC1N-PN1 had the lowest IC 50 value (0.86 
mg/mL freeze-dry BPIH extract) for DPP-IV inhibition among the four cultivars. SARC1 had 
the highest IC 50 value, while Sanilac and SMARC1-PN1 had similar IC 50 value.  
Many former studies have indicated that common bean protein hydrolysates have DPP-IV 
inhibition properties, and identified many small bio-peptides, such as the sequences FATGT  
and  in Black bean, and in Navy bean, etc. (Mojica et al., 
2015; Oseguera-Toledo et al., 2015; Oseguera-Toledo et al., 2016). Unexpectedly, my results 
revealed that the active compounds that had DPP-IV inhibition property in BPIH were 
probably not peptides (Figure 3 - 13). According to the LC-MS/MS identification, the DPP-
IV enzyme may be inhibited by lipids found in common bean, such as monoacylglycerol 
(MG), phosphatidylglycerol (PG), phosphatidylethanolamine (PE), and phosphatidylcholine 




Table 3 - 10). It is a new discovery in this area with no similar report in the literature, at least 
to my knowledge, so further in vitro and in vivo experiments are needed to prove this finding. 
One of the active compounds we identified was possibly MG (0:0/18:3/0:0), its putative 
formula was C21H36O4, and it belongs to monoacylglycerols, which are composed of glycerol 
linked to a fatty acid by an ester bond (Long et al., 2009). MG (0:0/18:3/0:0) was a potential 
important compound since it was only detected in the 70% MeOH fraction and SMARC1N-
PN1 BPIH (ID 37 in Table 3 - 9). MG (0:0/18:3/0:0) can be found in low concentration (1 - 
3%) in the derivatized common bean fatty acid profile (David et al., 2019). Since the 
powerful emulsifier of monoacylglycerol can cause membrane damage et al., 
2013), the strong detergent of MG (0:0/18:3/0:0) might relate to the DPP-IV enzyme 
inhibition based on the fact that DPP-IV enzyme is expressed on the surface of most cell 
types. In future studies, it would be of interest to purify this compound from the BPIH or 
obtain this compound from a commercial manufacturer and test for the DPP-IV inhibition 
individually. 
PG (16:0/0:0) was another possible active compound identified by LC-MS/MS; the putative 
formula of this compound is C22H45O9P and it belongs to phosphatidylglycerols. This 
compound was only detected in the 70% MeOH fraction but not in the SMARC1N-PN1 
BPIH extract (row ID 24 in Table 3 - 9). Consider that the environment in BPIH is more 
complex than in fractions, some compounds might have been observed in a fraction but 
below the limit of detection or at low levels in the BPIH extract that can be detected. Thus, 
PG could still be a potential candidate for inhibiting DPP-IV enzyme. PG is an anionic 
phospholipid and has been found in almost all organisms (Wada and Murata, 2007). Previous 
studies mainly focused on how PG in chloroplasts can help to complete photosynthetic light 
reactions and electron transport because it is the only phospholipid found in the thylakoid 
membrane of the chloroplast to play a special role in photosynthesis (Gombos et al., 2002; 
Hagio et al., 2002; Sato et al., 2000), while the finding in my project might reveal a new 
potential function of PG in common bean seeds. Future work can focus on purifying this 
compound from the BPIH or buy this compound and test for DPP-IV inhibition individually. 
PE (18:0/0:0) was identified as a possible active compound; its putative formula is 
C23H48NO7P and it belongs to phosphatidylethanolamines. It was only detected in the 70% 
MeOH fraction and not in the SMARC1N-PN1 BPIH (row ID 22 in Table 3 - 9). PE is a 




second most abundant phospholipid in the plant after phosphatidylcholine (Mizoi et al., 2003). 
The content of PE in mitochondrial membrane is particularly high, especially in the inner 
membrane, where its content is much higher than that in other organelles, this suggests that 
PE contributes to many mitochondria functions such as oxidative phosphorylation through 
the electron transport chain (Ball et al., 2018). According to my results, PE (18:0/0:0) might 
also have DPP-IV inhibition properties. Future studies involve purification of this compound 
from the BPIH or purchasing this compound and test for the DPP-IV inhibition individually. 
Five more different phosphatidylcholines (PC) were identified as possible active compounds 
that may have inhibitory properties for the DPP-IV enzyme, and their putative formula are 
C29H60NO7P, C29H60NO8P, C31H64NO7P, C42H76NO8P, and C44H78NO8P (row ID 2, 14, 1, 18, 
3, respectively, in Table 3 - 9). Phosphatidylcholine mainly exists in the cells of animals and 
plants and may offer many benefits for human health. It is the major component of the cell 
membrane of living organisms. The oilseed crops are usually rich in phosphatidylcholine. 
Soybean lecithin is a good example of phosphatidylcholine, it constitutes not only an 
important part of the biological membrane but also is a source of choline and fatty acids, 
which play key roles in maintaining the physiological activity of biological membranes and 
the normal metabolism of the human body (List, 2015). In the literature are reports that PC 
can maintain liver health, cardiovascular, and brain health (Lieber et al., 1990; Miller, 2002; 
Smith et al., 2016), while the findings in my project might reveal a new potential function of 
PC. 
 
4.2 Possible reasons that affect active common bean peptides 
For the digested common bean peptides after cooking, there is ample literature indicating that 
they work for -amylase and -glucosidase inhibition (Mojica et al., 2015; Oseguera-Toledo 
et al., 2015) and DPP-IV enzyme inhibition properties (Mojica et al., 2015; Mojica and de 
Mejía, 2016; Oseguera-Toledo et al., 2016). Soybean peptides were identified that had anti-
lipogenic property (Martinez-Villaluenga et al., 2008; Martinez-Villaluenga et al., 2009), 
which prompted us to explore if common bean digested peptides also have similar anti-
lipogenic ability. However, common bean peptides isolated in this study did not appear to 
exhibit enzyme inhibition properties that listed above. The possible reasons might relate to 





4.2.1 Cooking process might influence the quality and nutritional 
value of common beans 
In many developing countries where animal proteins are expensive, common bean has 
become a staple food for many low-income people in both rural and urban areas because of 
the high protein content (19-27%) and other nutrients (Lima et al., 2005). Despite its high 
nutritional value and its functional properties, the common bean does have some drawbacks, 
this -to- (HTC) phenomenon due to the deterioration of the 
texture and flavor and the prolonged cooking time required due to the hardening of the beans 
(Oseguera-Toledo et al., 2015). The HTC phenomenon reduces the nutritional value of 
common been seeds by inhibiting the separation of cells during cooking, which affects the 
texture of seeds after cooking and limits the breakdown of proteins by digestive enzymes 
(Batista et al., 2010). 
Different cooking processes can significantly affect the nutritional value of common bean. 
According to Batista et al. (2010), extrusion during cooking of common bean could increase 
the digestibility of proteins and starch by reducing the activity of antinutritional factors such 
-amylase inhibitors, which might explain why the BPIH for the four cultivars 
did not inhibit the -amylase -glucosidase enzyme (Error! Reference source not found. 
and Figure 3 - 2). Moreover, previous studies used additional steps before cooking the bean, 
such as soaking the beans overnight to remove the hull (Oseguera-Toledo et al., 2015); 
blanching the beans and putting them under high pressure or oven-dry before cooking (also 
called precooking) (Mojica et al., 2015); or grinding beans into powder (Batista et al., 2010). 
Some studies suggested cooking beans by autoclaving instead of boiling them (Oseguera-
Toledo et al., 2015), or performed protein extraction first from the ground common bean 
powder, then autoclaved at a high temperature and pressure before protein hydrolysis (Mojica 
and de Mejía, 2016). All these differences might explain why there were no active peptides 
found in my project that exhibited -amylase and -glucosidase inhibition, DPP-IV enzyme 





4.2.2 Bean varieties influence the quality and nutritional value of 
beans 
Based on the fact that the protein profiles vary in different common bean cultivars, the 
common bean cultivars in this project might also explain why there were not active peptides 
exhibiting -amylase and -glucosidase inhibition, DPP-IV enzyme inhibition, antimicrobial, 
or anti-lipogenic properties. Previous research has focused on the well-known common bean 
market classes such as lack , Red , Na Great Northern  and Pinto , which the 
main storage proteins found in these commercial cultivars is phaseolin (Batista et al., 2010; 
Mojica et al., 2015), and indeed found bioactive peptides associated with the capacities listed 
above. The germplasm lines SARC1, SMARC1-PN1 and SMARC1N-PN1 are relatively new 
and less studied. This project might indicate that different common bean genotypes may have 
different abilities, which require more experiments to focus on a specific genotype and 




Chapter 5: Conclusions 
5.1 Concluding remarks and Future studies 
As one of the most common commercial crops, the common bean provides adequate nutrition, 
with relatively high protein content and several health benefits. Although numerous studies 
have revealed health benefits from common bean consumption, few have focused on 
common bean bioactive peptides (from cooked and digested beans) and attempted to identify 
if they have -amylase and -glucosidase inhibition, antioxidant capacity, DPP-IV inhibition, 
antimicrobial ability, and anti-lipogenic properties. The goals of this project were to 
characterize and identify bioactive peptides specialized for antioxidant capacity, DPP-IV 
inhibition, -amylase and -glucosidase inhibition, and antimicrobial ability derived from the 
digestion of cooked common bean extracts, and determine the anti-lipogenic ability in 
cultured murine adipocyte cells. Our results indicate that cooked common bean indeed had 
some antioxidant, antimicrobial and anti-diabetic properties, but lacked -amylase, -
glucosidase inhibition, and anti-lipogenic ability. Moreover, SMARC1N-PN1 had higher 
antioxidant capacity, DPP-IV inhibition, and antimicrobial properties than the other 3 
varieties. 
As expected, the active compounds for antioxidant capacity were probably a mixture of small 
peptides because the majority of peptides were eluted into the active fractions for antioxidant 
capacity. However, the active compounds for antimicrobial properties were probably not 
peptides. This is a potentially new finding for antibacterial resources against drug resistance, 
but the information is limited concerning the nature of the bioactive molecules, requiring 
further investigation. DPP-IV may be inhibited by lipids, such as monoacylglycerols, 
phosphatidylglycerol, phosphoethanolamine, and phosphatidylcholine, which is an 
unexpected result and new discovery in this area, with no similar report in the literature to the 
best of my knowledge. Future work should focus on testing each identified compound for the 
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